Comparison of MRI (including SS SE-EPI and SPIO-enhanced MRI) and FDG-PET/CT for the detection of colorectal liver metastases

European Radiology

Volumn 19, Issue 2, 2009, Pages 370-379

  Coenegrachts, Kenneth ^a   De Geeter, Frank ^a   ter Beek, Leon ^b   Walgraeve, Natascha ^a   Bipat, Shandra ^c   Stoker, Jaap ^c   Rigauts, Hans ^a  

^a AZ St Jan AV ^*  (Belgium)

^b PHILIPS HEALTHCARE   (United States)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Diffusion magnetic resonance imaging; Ferucarbotran; Liver; Magnetic resonance imaging; Positron emission tomography

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; IOPROMIDE; IRON OXIDE; MEGLUMINE IOXITALAMATE PLUS SODIUM IOXITALAMATE; TELEBRIX GASTRO 300; UNCLASSIFIED DRUG;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SCINTISCANNING; CLINICAL ARTICLE; COLORECTAL CARCINOMA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHO PLANAR IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMAGE PROCESSING; INTERMETHOD COMPARISON; LIVER METASTASIS; LIVER SCINTISCANNING; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TREATMENT DURATION; TUMOR VOLUME;

AGED; COLORECTAL NEOPLASMS; CONTRAST MEDIA; FEMALE; FERRIC COMPOUNDS; FLUORODEOXYGLUCOSE F18; HUMANS; IRON; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM METASTASIS; OXIDES; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 59249102087     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-008-1163-y     Document Type: Article

References (30)

1. Ward J (2006) New MR techniques for the detection of liver metastases. Cancer Imaging 6:33-42
2. Kinkel K, Lu Y, Both M et al (2002) Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR Imaging, PET): A meta-analysis. Radiology 224:748-756
3. Semelka R, Martin D, Balci C et al (2001) Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging 13:397-401
4. Martin D, Semelka R (2001) Imaging of benign and malignant focal liver lesions. Magn Reson Imaging Clin N Am 9:785-802
5. Rappeport E, Loft A, Berthelsen A et al (2007) Contrast-enhanced FDG-PET/ CT vs. SPIO-enhanced MRI vs. FDGPET vs. CT in patients with liver metastases from colorectal cancer: A prospective study with intraoperative confirmation. Acta Radiol 48:369-378
6. Coenegrachts K, Orlent H, ter Beek L et al (2008) Improved focal liver lesion detection: Comparison of single-shot spin-echo echo-planar and superparamagnetic iron oxide (SPIO)-enhanced MRI. J Magn Reson Imaging 27:117-124
7. Boykin K, Zibari G, Lilien D et al (1999) The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver. Am J Surg 65:1183-1185
8. Delbeke D, Vitola J, Sandler M et al (1997) Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med 38:1196-1201
9. Zhuang H, Sinha P, Pourdehnad M et al (2000) The role of positron emission tomography with fluorine-18-deoxyglucose in identifying colorectal cancer metastases to liver. Nucl Med Commun 21:793-797
10. Bipat S, van Leeuwen M, Comans E et al (2005) Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-metaanalysis. Radiology 237:123-131
11. Cascini G, Avallone A, Delrio P et al (2006) 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. J Nucl Med 47:1241-1248
12. Mawlawi O, Podoloff D, Kohlmyer S (2004) Performance characteristics of a newly developed PET/CT scanner using NEMA standards in 2D and 3D modes. J Nucl Med 45:1734-1742
13. Kehagias D, Gouliamos A, Smyrniotis V et al (2001) Diagnostic efficacy and safety of MRI of the liver with superparamagnetic iron oxide particles (SH U 555 A). J Magn Reson Imaging 14:595-601
14. Kim J, Kim M, Suh S et al (2002) Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: Utility of T1-weighted spoiled gradient recalled echo images using different echo times. J Magn Reson Imaging 15:573-583
15. Grangier C, Tourniaire J, Mentha G et al (1994) Enhancement of liver hemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles. J Comput Assist Tomogr 18:888-896
16. Denys A, Arrive L, Servois V et al (1994) Hepatic tumors: Detection and characterization at 1-T MR imaging enhanced with AMI-25. Radiology 193:665-669
17. Seneterre E, Taourel P, Bouvier Y et al (1996) Detection of hepatic metastases: Ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 200:785-792
18. Ward J, Naik K, Guthrie J et al (1999) Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Radiology 210:459-466
19. Oudkerk M, van den Heuvel A, Wielopolski P et al (1997) Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging. Radiology 203:449-456
20. Akhurst T, Kates T, Mazumdar M et al (2005) Recent chemotherapy reduces the sensitivity of [18 F] fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases. J Clin Oncol 23:8713-8716
21. Bohm B, Voth M, Geoghegan J et al (2004) Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors. J Cancer Res Clin Oncol 130:266-272
22. Fong Y, Saldinger P, Akhurst T et al (1999) Utility of 18 F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg 178:282-287
23. Imdahl A, Reinhardt M, Nitzsche E et al (2000) Impact of 18F-FDG positron emission tomography for decision making in colorectal cancer recurrences. Arch Surg 385:129-134
24. Lai D, Fulham M, Stephen M et al (1996) The role of wholebody positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. Arch Surg 131:703-707
25. Rohren E, Paulson E, Hagge R et al (2002) The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases from colorectal cancer. Clin Nucl Med 27:550-555
26. Ruers T, Langenhoff B, Neeleman N et al (2002) Value of positron emission tomography with [F-18] fluorodeoxyglucose in patients with colorectal liver metastases: A prospective study. J Clin Oncol 20:388-395
27. Rydzewski B, Dehdashti F, Gordon B et al (2002) Usefulness of intraoperative sonography for revealing hepatic metastases from colorectal cancer in patients selected for surgery after undergoing FDG PET. AJR Am J Roentgenol 178:353-358
28. Truant S, Huglo D, Hebbar M et al (2005) Prospective evaluation of the impact of [18F]fluoro-2-deoxyglucose positron emission tomography of respectable colorectal liver metastases. Br J Surg 92:362-369
29. Vitola J, Delbeke D, Sandler M et al (1996) Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg 171:21-26
30. Sahani D, Kalva S, Fischman A et al (2005) Detection of liver metastases from adenocarcinoma of the colon and pancreas: Comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET. AJR Am J Roentgenol 185:239-246